Portage Biotech (PRTG) announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a ...
5d
Combining PORT-6 and PORT-7 for a More Comprehensive Immunotherapy Approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback